Therma Bright Inc. (TSXV: THRM)
Market Cap | 11.08M |
Revenue (ttm) | 25.85K |
Net Income (ttm) | -2.62M |
Shares Out | 443.14M |
EPS (ttm) | -0.01 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 86,600 |
Open | 0.0250 |
Previous Close | 0.0250 |
Day's Range | 0.0250 - 0.0300 |
52-Week Range | 0.0050 - 0.1000 |
Beta | 3.07 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Nov 28, 2024 |
About Therma Bright
Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. The company’s products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therapy device for pain relief without pain relieving medication; V... [Read more]
Financial Performance
In 2023, Therma Bright's revenue was 23,899, a decrease of -82.86% compared to the previous year's 139,427. Losses were -3.77 million, -35.93% less than in 2022.
Financial StatementsNews
Therma Bright to Spin Off Consumer Product Portfolio to Create Two Publicly Traded Companies
Toronto, Ontario--(Newsfile Corp. - November 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF), a leading developer and investment partner in advanced diagnostic and medical device technologi...
Therma Bright Announces Shares for Debt Issuance
Toronto, Ontario--(Newsfile Corp. - November 11, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leadin...
Therma Bright's Investment Partnership InStatin Joins Forces with InVixa to Enhance Its Patent Portfolio For The Development Of Innovative Respiratory Solutions
InStatin to secure exclusive worldwide licensing agreement of InVixa's inhaled statin solution to prevent and treat acute lung disease Toronto, Ontario--(Newsfile Corp. - October 28, 2024) - Therma Br...
Therma Bright Announces Shares for Debt Issuance
Toronto, Ontario--(Newsfile Corp. - October 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range...
Therma Bright Announces Quantify Medical as Nationwide U.S. Distribution Partner from August 22, 2024 Press Release
Quantify Medical Sees Initial Success with Venowave VW5 Sales and Medicare/Medicaid Reimbursement Test Therma Bright Closes First Tranche of Non-Brokered Concurrent Private Placement for CAD $174,900 ...
Therma Bright to raise C$6M via LIFE financing and private placement
Therma Bright Announces Non-Brokered LIFE Financing & Concurrent Private Placement for up to a combined CAD$6 Million
LIFE Financing and Concurrent Private Placement to Include Common Shares Only and no Warrants Toronto, Ontario--(Newsfile Corp. - September 27, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (...
Therma Bright Investment Portfolio Company InStatin Secures Mountain West Research Discovery Study Agreement
Clinical research will offer insight for specific targeting of active pharmaceutical ingredients (API) that will further support Phase 1 Human Trials. Toronto, Ontario--(Newsfile Corp. - September 23,...
Therma Bright Announces Shares for Debt Issuance to Include Portfolio Company AI4LYF & IR Agreement
Toronto, Ontario--(Newsfile Corp. - September 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"), a developer and investment partner in a wide range of leadi...
Therma Bright Welcomes Medical Device & Pharmaceutical Veteran Douglas S. Sommerville to Its Advisory Board
New Advisory Board Member will focus on Venowave sales and business development efforts Toronto, Ontario--(Newsfile Corp. - September 12, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therm...
Therma Bright Congratulates John Patton, PhD of InStatin on Receiving the Prestigious Charles G. Thiel Award
Chairman of Therma Bright's Strategic Investment Partner Recognized for Outstanding Research and Discovery in Respiratory Drug Delivery Toronto, Ontario--(Newsfile Corp. - September 4, 2024) - Therma ...
Therma Bright Major Milestone: Portfolio Company Inretio's Preva(R) Device Achieves 3rd Human Trial Success
Game-Changing Innovation Poised to Transform Stroke and Blood Clot Treatment Therma Bright's Strategic Investment Helps Medical Device Company Demonstrate Efficacy and Safety in Transforming Ischemic ...
RETRANSMISSION: Therma Bright Secures Nationwide U.S. Distribution Partner For Venowave
Nationwide partner launches initial Venowave sales program to gauge Medicare/Medicaid reimbursement timelines and billing procedures Post initial program success, distributor commits to acquire remain...
Therma Bright Secures Nationwide U.S. Distribution Partner For Venowave
Nationwide partner launches initial Venowave sales program to gauge Medicare/Medicaid reimbursement timelines and billing procedures Post initial program success, distributor commits to acquire remain...
Therma Bright's Venowave VW5 Secures Permanent HCPCS Code E0683 from U.S. DHHS's Centers for Medicare & Medicaid Services
The device becomes the first-of-its-kind Durable Medical Equipment to receive a new HCPCS Level II designation Company looks to provide a U.S. sales update in the coming week Toronto, Ontario--(Newsfi...
Therma Bright's AI-Powered Digital Cough Technology Being Considered as Partner Technology in New Chronic Cough Drug Clinical Trial
Toronto, Ontario--(Newsfile Corp. - August 16, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, p...
Therma Bright Welcomes Medical & Pharmaceutical Veteran Michael Raimondo to Its Advisory Board
New Advisory Board Member Will Initially Focus On Venowave Sales & Business Development Toronto, Ontario--(Newsfile Corp. - August 13, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" ...
Therma Bright Expands InStatin Investment
Toronto, Ontario--(Newsfile Corp. - August 6, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, pr...
Therma Bright Receives Positive Notification from U.S. DHHS's Centers for Medicare & Medicaid (CMS)
Company anticipates CMS permanent CPT(R) and HCPCS codes in the coming days Toronto, Ontario--(Newsfile Corp. - August 1, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Compa...
Therma Bright's Venowave VW5 Secures FDA 510K Approval
Toronto, Ontario--(Newsfile Corp. - July 29, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, pro...
Therma Bright Engages Independent Trading Group as Market Maker
Toronto, Ontario--(Newsfile Corp. - July 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner in a wide range of leadin...
Therma Bright Q2, 2024 Market Update On Business
Medical Device Developer & Investor Taps 4 Markets With Growth Projections of USD $39.1B by 2030 Toronto, Ontario--(Newsfile Corp. - July 3, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Th...
Therma Bright Closes Second & Final Tranche of Fully Subscribed Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - June 21, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, pro...
Therma Bright Completes Debt Settlements
Toronto, Ontario--(Newsfile Corp. - June 19, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, pro...
Therma Bright Closes $854,500 First Tranche of Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - June 10, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in a wide range of leading-edge, pro...